Eric P. Krenning

Cyclotron (Netherlands)

Publishes on Neuroendocrine Tumor Research Advances, Radiopharmaceutical Chemistry and Applications, Lung Cancer Research Studies. 355 papers and 34.2k citations.

PubIndex Score98Top 2%How it's scored

🌟#1 Current Senior Leader in Lung Cancer Research Studies 🌟#2 Current Senior Leader in Neuroendocrine Tumor Research Advances 🌟#8 Current Senior Leader in Neuroblastoma Research and Treatments

355Publications

34.2kTotal Citations

#1in Lung Cancer Research Studies

First publication: 1980First senior author: 1988

Neuroendocrine Tumor Research Advances Radiopharmaceutical Chemistry and Applications Lung Cancer Research Studies Neuroblastoma Research and Treatments Peptidase Inhibition and Analysis

Top publicationsby citations

Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Eric P. Krenning, Ghassan El‐Haddad et al.|New England Journal of Medicine|2017

Cited by 3.2k

Gastroenteropancreatic neuroendocrine tumours

Irvin M. Modlin, Anders Sundin, Kjell Öberg et al.|The Lancet Oncology|2008

Cited by 1.8k

Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Eric P. Krenning, Wouter W. de Herder et al.|Journal of Clinical Oncology|2008

Cited by 1.4k

ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

Ramón Salazar, Éric Baudin, Anne Couvelard et al.|Neuroendocrinology|2012

Cited by 869

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

STEVEN W. J. LAMBERTS, Jean–Claude Reubi, Eric P. Krenning|Endocrine Reviews|1991

Cited by 814